Clinical trials of semaglutide (another GLP-1 agonist) showed a temporary increase in diabetic retinopathy complications, particularly in patients with pre-existing retinopathy who experienced rapid glycemic improvement
Data from the EudraVigilance and other drug safety databases relies on spontaneous reporting which may introduce reporting bias, underreporting adverse events and missing information
These products are not intended for human consumption, veterinary use, therapeutic use, diagnostic use, or resale as consumer goods
Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach
Standardowe protokoy laboratoryjne podsumowano poniej badacze powinni walidowa je wzgldem wasnych SOP
Mukherjee, A., Ghaem-Maghami, S., & Syed, A